Kratom : legislative update
The recently released Hemby study : https://onlinelibrary.wiley.com/doi/10.1111/adb.12639 published in Addiction Biology sent shock waves through the FDA corridors with the finding that mitragynine, the major alkaloid in kratom, “does not have an abuse potential and reduces morphine intake” which is exactly the pharmacologic activity for “candidate pharmacotherapies for opiate addiction and withdrawal.” This study directly challenges the…
Recent Comments